e-learning
resources
Breathe
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Acute exacerbations of idiopathic pulmonary fibrosis and the role of corticosteroids
Christopher J. Brereton, Helen E. Jo
Source:
Breathe, 16 (3) 200086; 10.1183/20734735.0086-2020
Journal Issue:
September
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Christopher J. Brereton, Helen E. Jo. Acute exacerbations of idiopathic pulmonary fibrosis and the role of corticosteroids. Breathe, 16 (3) 200086; 10.1183/20734735.0086-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Acute exacerbation of idiopathic pulmonary fibrosis
Source: Eur Respir J 2004; 23: 792
Year: 2004
Asymmetry in acute exacerbation of idiopathic pulmonary fibrosis
Source: ERJ Open Res, 3 (2) 00036-2016; 10.1183/23120541.00036-2016
Year: 2017
Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis
Source: Eur Respir J, 49 (5) 1601339; 10.1183/13993003.01339-2016
Year: 2017
Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 624s
Year: 2006
Intravenous pulse doses of high-dose corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2016 – Russia Session
Year: 2016
The efficacy of anti-fibrotic agents for acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017
Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm
Source: Eur Respir J 2015; 46: 512-520
Year: 2015
Diagnosis and therapy of acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) in Germany
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis
Source: Eur Respir J 2012; 40: 93-100
Year: 2012
A proof of concept study by thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J, 50 (4) 1701157; 10.1183/13993003.01157-2017
Year: 2017
Differences of acute exacerbations in idiopathic pulmonary fibrosis compared to other fibrotic lung diseases
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019
Role of non-cystic fibrosis bronchiectasis in hospitalized patients with acute exacerbation of COPD
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017
Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease
Source: Eur Respir Rev 2009; 18: 129-132
Year: 2009
Prognostic factors analysis of patients with acute exacerbation of idiopathic interstitial pneumonias treated by polymyxin B hemoperfusion
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
The challenge of acute exacerbation of pulmonary fibrosis
Source: International Congress 2014 – PG01 Challenges faced when diagnosing idiopathic interstitial lung disease
Year: 2014
Inhaled corticosteroids and survival in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 202-203
Year: 2003
Acute exacerbation in combined pulmonary fibrosis and emphysema (CPFE): what special features?
Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases
Year: 2020
Antibiotics in acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept